Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Terminated × capmatinib × Clear all

Phase

Phase 2 5 Phase 1/2 3 Phase 1 2 Phase 3 1

Status

Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 46 Carboplatin 44 Radiotherapy 39 Paclitaxel 39 Docetaxel 36 Gemcitabine 32 Cyclophosphamide 32 Rituximab 26 Fluorouracil 25 Doxorubicin 24 Dexamethasone 24 Capecitabine 22 Bevacizumab 19 Prednisone 18 Oxaliplatin 16 Leucovorin 16 Vincristine 15 Etoposide 14 Cytarabine 14 Drug Therapy 13 pembrolizumab 12 Zoledronic Acid 12 Radiosurgery 12 Pemetrexed 12 Irinotecan 12 Imatinib Mesylate 12 Filgrastim 12 Surgical Procedures, Operative 10 Standard of Care 10 Goserelin 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04427072 2025-05-16

GeoMETry-III

Novartis

Phase 3 Terminated

22 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡